Fetal Monitoring, Diagnostics and Predictive Tests

Fetal Monitoring, Diagnostics and Predictive Tests

Report Code: HLC089A

Publish Date: Apr 2011

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for fetal monitoring, diagnostics, and predictive tests reached approximately $6.2 billion in 2010.  The market is expected to rise at a compound annual growth rate (CAGR) of 4.4% and reach approximately $8 billion by 2016.

SCOPE OF THE STUDY

The scope of this study encompasses the fetal monitoring and diagnostics markets.  BCC analyzes each market and its applications by its need for usage in different stages of pregnancy, along with the regulatory environment, technology involved, market projections, and market share.  Technological issues include the latest trends and developments. 

ABOUT THE AUTHOR

The study has been carried out by a team of professionals in the biotechnology industry.  The project manager is Shalini S. Dewan, who holds a Master’s degree in Pharmaceutical Chemistry and has more than 14 years of industry experience.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid.  Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and the U.S.  Her other reports with BCC Research include Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems: New Developments, New Technologies; Orthopedic Drugs, Implants and Devices; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; Cancer Therapies: Technologies and Global Markets; and Medical Imaging Reagents and Analysis Equipment. 

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in Life Sciences.  She has a number of research publications to her credit, including her thesis on Studies on Phenotypic Variation, Clonal Propagation, and Phyto-chemistry of Tinospora cordifolia (Willd.). 

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Fetal Monitoring, Diagnostics and Predictive Tests145Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY3Free
Chapter- 3: OVERVIEW18Free
Chapter- 4: REGULATORY ASPECTS10Free
Chapter- 5: CLASSIFICATION7Free
Chapter- 6: TESTS FOR GENETIC DISORDERS6Free
Chapter- 7: INDUSTRY STRUCTURE16Free
Chapter- 8: NEW DEVELOPMENTS4Free
Chapter- 9: MARKET ANALYSIS26Free
Chapter- 10: MARKET BY APPLICATIONS 11Free
Chapter- 11: PATENT ANALYSIS11Free
Chapter- 12: FETAL MONITORING AND PRENATAL DIAGNOSTICS TO HELP REDUCE STILLBIRTHS2Free
Chapter- 13: CURRENT SITUATION AND MARKET PROSPECTS4Free
Chapter- 14: C. CRAMER & CO. GMBH21Free
Chapter- 15: APPENDIX I: ABBREVIATIONS AND DEFINITIONS2Free

Related Reports

Organ and Tissue Transplantation and Alternatives

Published - Jan 2011 | Publisher - Peggy Lehr | Code - HLC012E

The global market for transplantation products, devices, and pharmaceuticals was valued at nearly $54 billion in 2010 and is projected to grow at an 8.3% compound annual growth rate (CAGR) to reach $80 billion in 2015.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 47

  • Summary Table: GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, THROUGH 2016
  • Table 1: ADVANTAGES AND DISADVANTAGES OF EXTERNAL FETAL MONITORING
  • Table 2: ADVANTAGES AND DISADVANTAGES OF INTERNAL FETAL MONITORING
  • Table 3: EXTERNAL FETAL MONITORING VERSUS INTERNAL FETAL MONITORING
  • Table 4: ULTRASOUND VERSUS MRI
  • Table 5: PRE-MARKET APPROVALS, 2006 TO DECEMBER 2010
  • Table 6: LEADING MANUFACTURERS AND SUPPLIERS OF FETAL DOPPLERS
  • Table 7: LEADING MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS
  • Table 8: LEADING MANUFACTURERS AND SUPPLIERS OF FETAL SCALP ELECTRODES, FETOSCOPES, AND CATHETERS
  • Table 9: LEADING MANUFACTURERS AND SUPPLIERS OF ULTRASOUND SYSTEMS
  • Table 10: LEADING MANUFACTURERS AND SUPPLIERS OF MRI SYSTEMS
Sample Report

Recent Reports

Anesthesia and Respiratory Devices: Global Markets

Published - Aug 2025 | Publisher - BCC Publishing | Code - HLC167E

The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.

Tissue Engineering and Regeneration: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC101E

The global market for tissue engineering and regeneration was valued at $4.8 billion in 2024 and is estimated to increase from $5.4 billion in 2025 to reach $9.8 billion by 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

6G in Healthcare: Global Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC306A

This report provides an analysis of the global market trends for 6G in healthcare. It focuses on the significant driving trends and challenges that affect the global market. The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key companies in the global market for 6G in healthcare.

Healthcare Innovation in the GCC

Published - Jul 2025 | Publisher - BCC Publishing | Code - HLC307A

The report provides an analysis of the healthcare landscape in the Gulf Cooperation Council (GCC) countries. The report estimates the Total Addressable Market (TAM) for the GCC healthcare sector from 2024 to 2030, offering country-specific projections. This analysis provides critical insights into the commercial potential and investment opportunities in the region’s rapidly evolving healthcare ecosystem. The countries included in the analysis are Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Oman, and Bahrain.

Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa

Published - Jun 2025 | Publisher - BCC Publishing | Code - HLC305A

This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Fetal Monitoring, Diagnostics and Predictive Tests
Customize Report